These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30842350)

  • 1. One-Year Clinical Outcomes following Implantation of Innova
    Tsujimura T; Takahara M; Iida O; Hiramori S; Hayakawa N; Karashima E; Miura T; Teramura M; Ichihashi K; Kojima T; Aihara H; Yamaoka T; Fujihara M; Tosaka A; Doijiri T; Mano T; Soga Y
    J Atheroscler Thromb; 2019 Oct; 26(10):847-855. PubMed ID: 30842350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year Clinical Outcomes Post Implantation of Epic
    Tsujimura T; Iida O; Fujita M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Okuno S; Matsuda Y; Fujihara M; Yokoi Y; Mano T
    J Atheroscler Thromb; 2018 Apr; 25(4):344-349. PubMed ID: 28978866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.
    Sakamoto Y; Hirano K; Iida O; Soga Y; Suzuki K; Muramatsu T; Tsukahara R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E251-6. PubMed ID: 23536429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.
    Wressnegger A; Kaider A; Funovics MA
    Trials; 2017 Dec; 18(1):594. PubMed ID: 29237489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
    Park SH; Rha SW; Choi CU; Kim EJ; Oh DJ; Cho YH; Choi WG; Lee SJ; Kim YH; Choi SH; Kim WH; Kim KC; Cho JH; Kim JH; Kim SM; Bae JH; Bong JM; Kang WY; Baek JY; Seo JB; Chung WY; Park MW; Her SH; Suh J; Kim MW; Kim YJ; Choi HJ; Soh JW;
    Trials; 2014 Sep; 15():355. PubMed ID: 25208688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Year Clinical Outcomes Following Implantation of LifeStent Self-Expanding Nitinol Stents in Patients With Femoropopliteal Artery Lesions.
    Tan M; Takahara M; Soga Y; Mori S; Tsuchiya T; Mazaki T; Shintani Y; Noguchi M; Taniguchi M; Kobayashi Y; Nakazato J; Urasawa K
    Angiology; 2022 Mar; 73(3):244-251. PubMed ID: 34493086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
    J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Year Clinical Outcomes of the Innova™ Self-Expanding Nitinol Stent for the Treatment of Femoropopliteal Lesions.
    Karashima E; Takahara M; Hozawa K; Yamauchi Y; Suzuki K; Suematsu N; Miyashita Y; Enomoto S; Tokuyama H; Murata N; Haraguchi K; Soga Y
    Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1722-1727. PubMed ID: 34523023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
    Powell RJ; Jaff MR; Schroë H; Benko A; Diaz-Cartelle J; Müller-Hülsbeck S
    Catheter Cardiovasc Interv; 2017 May; 89(6):1069-1077. PubMed ID: 28296239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
    Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
    J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center.
    Kim W; Gandhi RT; Peña CS; Herrera RE; Schernthaner MB; Acuña JM; Becerra VN; Katzen BT
    J Vasc Interv Radiol; 2016 Oct; 27(10):1494-501. PubMed ID: 27522274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions.
    Dohi T; Iida O; Soga Y; Hirano K; Suzuki K; Takahara M; Uematsu M; Nanto S
    J Vasc Surg; 2014 Apr; 59(4):1009-1015.e1. PubMed ID: 24360237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.